A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants
Clinical trial NCT06116617 · COMPLETED
Trial details
- NCT number
- NCT06116617
- Sponsor
- Sirius Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2024-12-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.